Fred Telling - 29 Jun 2021 Form 4 Insider Report for ORAGENICS INC (OGEN)

Role: Director
Signature: /s/ Mark A. Catchur, as Attorney-in-Fact for Frederick W. Telling
Issuer symbol: OGEN
Transactions as of: 29 Jun 2021
Net transactions value: +$75,139
Form type: 4
Filing time: 30 Jun 2021, 16:06:01 UTC
Next filing: 17 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OGEN	Common Stock	Options Exercise	$75,139	+156,540	+36%	$0.4800	596,078	29 Jun 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGEN	Non-Employee Director Option (Right to Buy)	Options Exercise	$0	-156,540	-100%	$0.000000^*	0	29 Jun 2021	Common Stock	156,540	$0.4800	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the exercise of a fully vested outstanding option award to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan.